Gujarat Themis Biosyn share news, announcements and annual reports
NSE: GUJTHEMBSE: 506879Pharmaceuticals & BiotechnologySmall Cap
Gujarat Themis Biosyn Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1984 on BSE, Feb 2025 on NSE
Last close ₹375.80up ₹20.25 (5.70%)BSE ₹374.85
Share price at the NSE close on 29 Oct 2026. Previous close ₹355.55.
29 Oct: open ₹353.00, high ₹377.50, low ₹352.60
52-week range of traded prices to 29 Oct 2026
₹225.05Low, 30 Mar 2026₹471.80High, 4 Nov 2025
- Next results date: the board meets on 4 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹4,891 Cr886th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 100.45
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.18%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 18.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 15.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.56
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,88,70145.9% delivered
Gujarat Themis Biosyn share news and announcements
99 announcements, routine notices left out, newest first. Page 2 of 2.
Jun 2026
18 Jun · Legal
Exchange has sought clarification from Gujarat Themis Biosyn Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted in XBRL with discrepancies. The response of the Company is awaited.17 Jun
8 Jun · Meeting
6 Jun · Board meeting
3 Jun · Board meeting
May 2026
29 May
25 May · Results
22 May · Business
20 May
19 May
5 May · Meeting
Apr 2026
23 Apr · Business
Mar 2026
18 Mar · Meeting
Feb 2026
5 Feb · Results
5 Feb · Board meeting
Jan 2026
30 Jan · Board meeting
14 Jan · Updates
7 Jan · Meeting
Dec 2025
Nov 2025
10 Nov · Results
10 Nov · Board meeting
Oct 2025
18 Oct · Business
Sep 2025
22 Sep · Legal
The exchange asked on 22 Sep 2025
12 Sep
Aug 2025
21 Aug · Business Responsibility and Sustainability Reporting (BRSR)
1 Aug · Results
1 Aug · Board meeting
Jul 2025
25 Jul · Board meeting
Jun 2025
13 Jun · General Updates
13 Jun · Board meeting
May 2025